Carisma Therapeutics Statistics
Total Valuation
CARM has a market cap or net worth of $71.04 million. The enterprise value is -$3.44 million.
| Market Cap | 71.04M |
| Enterprise Value | -3.44M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CARM has 41.54 million shares outstanding. The number of shares has increased by 1,475.33% in one year.
| Shares Outstanding | 41.54M |
| Shares Change (YoY) | +1,475.33% |
| Shares Change (QoQ) | -16.78% |
| Owned by Insiders (%) | 28.68% |
| Owned by Institutions (%) | 40.82% |
| Float | 22.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.76 |
| Forward PS | 4.20 |
| PB Ratio | 2.68 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.06, with a Debt / Equity ratio of 0.12.
| Current Ratio | 5.06 |
| Quick Ratio | n/a |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 45.88 |
Financial Efficiency
Return on equity (ROE) is -154.00% and return on invested capital (ROIC) is -299.21%.
| Return on Equity (ROE) | -154.00% |
| Return on Assets (ROA) | -71.60% |
| Return on Capital (ROIC) | -299.21% |
| Revenue Per Employee | $139,430 |
| Profits Per Employee | -$811,953 |
| Employee Count | 107 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.99% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | -57.99% |
| 50-Day Moving Average | 2.25 |
| 200-Day Moving Average | 3.75 |
| Relative Strength Index (RSI) | 33.27 |
| Average Volume (30 Days) | 163,830 |
Short Selling Information
The latest short interest is 1.58 million, so 3.81% of the outstanding shares have been sold short.
| Short Interest | 1.58M |
| Short Previous Month | 1.55M |
| Short % of Shares Out | 3.81% |
| Short % of Float | 7.03% |
| Short Ratio (days to cover) | 9.65 |
Income Statement
In the last 12 months, CARM had revenue of $14.92 million and -$86.88 million in losses. Loss per share was -$2.59.
| Revenue | 14.92M |
| Gross Profit | 14.92M |
| Operating Income | -88.73M |
| Pretax Income | -86.88M |
| Net Income | -86.88M |
| EBITDA | -80.55M |
| EBIT | -88.82M |
| Loss Per Share | -$2.59 |
Balance Sheet
The company has $77.61 million in cash and $3.12 million in debt, giving a net cash position of $74.48 million or $1.79 per share.
| Cash & Cash Equivalents | 77.61M |
| Total Debt | 3.12M |
| Net Cash | 74.48M |
| Net Cash Per Share | $1.79 |
| Equity / Book Value | 26.53M |
| Book Value Per Share | 0.64 |
| Working Capital | 64.56M |
Cash Flow
In the last 12 months, operating cash flow was -$81.18 million and capital expenditures -$1.13 million, giving a free cash flow of -$82.31 million.
| Operating Cash Flow | -81.18M |
| Capital Expenditures | -1.13M |
| Free Cash Flow | -82.31M |
| FCF Per Share | -$2.46 |
Margins
Gross margin is 100.00%, with operating and profit margins of -594.75% and -582.34%.
| Gross Margin | 100.00% |
| Operating Margin | -594.75% |
| Pretax Margin | -582.34% |
| Profit Margin | -582.34% |
| EBITDA Margin | -539.92% |
| EBIT Margin | -595.31% |
| FCF Margin | -551.71% |
Dividends & Yields
CARM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,475.33% |
| Shareholder Yield | -1,475.33% |
| Earnings Yield | -122.30% |
| FCF Yield | -115.87% |
Analyst Forecast
The average price target for CARM is $9.40, which is 449.71% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.40 |
| Price Target Difference | 449.71% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 42.77% |
| EPS Growth Forecast (5Y) | -28.79% |
Stock Splits
The last stock split was on March 8, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Mar 8, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
CARM has an Altman Z-Score of -5.4 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.4 |
| Piotroski F-Score | 4 |